Advancing Women's Health Research and Innovation
- Executive Order Number
- 14120
- President
- Joseph R. Biden Jr.
- Signed
- March 18, 2024
- Published
- March 21, 2024
- Source
- Federal Register
- Original Document
- https://www.govinfo.gov/content/pkg/FR-2024-03-21/pdf/2024-06123.pdf
AI-Generated Summary
Executive Order 14120: Advancing Women's Health Research and Innovation
Purpose
The purpose of Executive Order 14120, signed on March 18, 2024, is to advance women's health research, close health disparities, and ensure that research advancements are translated into real-world clinical benefits for women. The order aims to fundamentally change the approach and funding of women's health research in the United States.
Key Actions or Directives
- Establishment of the White House Initiative on Women's Health Research: Led by the First Lady, this initiative includes various executive departments and agencies to accelerate research on conditions that affect women uniquely, disproportionately, or differently.
- Integration of Women's Health Research: Agency Members of the Initiative are tasked with developing or strengthening research and data standards to enhance the study of women's health across federally funded research. This includes:
- Requiring applicants for federal research funding to explain how their proposed studies will advance knowledge of women's health.
- Considering women's health during the evaluation of research proposals.
- Improving accountability for grant recipients through regular reporting.
- Enhancing recruitment, enrollment, and retention of women in clinical trials.
- Prioritization of Federal Investments: Agencies are directed to prioritize grantmaking and other awards to advance women's health research, focusing on:
- Collaborative, interdisciplinary research.
- Addressing health disparities and inequities.
- Supporting the translation of research into improved health outcomes.
- Innovation and Commercialization: Agencies are encouraged to use innovation funds, challenges, and prizes to spur innovation in women's health, support small businesses and entrepreneurs, and invest in translational science.
- Research on Women's Midlife Health: The Secretary of Health and Human Services is tasked with assessing the current state of science on menopause and developing an evidence-based research agenda. The Secretaries of Defense and Veterans Affairs are to evaluate the needs of women service members and veterans related to midlife health.
- Assessment of Unmet Needs: The Director of the Office of Management and Budget (OMB) and the Director of the Gender Policy Council are to lead an effort to identify funding gaps and submit recommendations to the President on how to catalyze research on women's health.
Significant Changes to Policy or Law
- The order builds on existing legislative frameworks, such as the National Institutes of Health Revitalization Act of 1993 and the 21st Century Cures Act, by further emphasizing the inclusion of women in clinical research and the development of research standards.
- It introduces a structured approach to prioritize and integrate women's health research across federal agencies, which may lead to new policies and funding mechanisms.
Potential Impacts
- Government Agencies: Federal agencies will need to align their research and funding strategies with the order's directives, potentially requiring changes in how they allocate resources and evaluate research proposals.
- Citizens: Improved research on women's health could lead to better diagnostics, treatments, and health outcomes for women, particularly addressing disparities among women of color, older women, and women with disabilities.
- International Relations: While the order is domestic in focus, advancements in women's health research could contribute to global health knowledge and potentially influence international health policy.
Main Stakeholders Affected
- Federal Agencies: Including the Department of Health and Human Services, Department of Defense, Department of Veterans Affairs, Environmental Protection Agency, National Science Foundation, and others.
- Researchers and Scientists: Those involved in biomedical and health-related research will need to adapt to new research standards and funding priorities.
- Women: Particularly those affected by health disparities, including women of color, older women, and women with disabilities.
- Healthcare Providers: Who will benefit from new research findings and improved treatments.
- Small Businesses and Entrepreneurs: Encouraged to innovate in women's health research and commercialization.
Notable Legal, Constitutional, or Political Implications
- Legal Implications: The order does not create enforceable rights or benefits but directs agencies to use existing authorities to advance women's health research. Agencies must implement the order consistent with applicable law and subject to the availability of appropriations.
- Constitutional Implications: The order is grounded in the President's executive authority to direct federal agencies and does not appear to raise significant constitutional issues.
- Political Implications: The order reflects a policy priority of the administration to address women's health issues, potentially influencing public discourse and future legislative agendas on health research and funding.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.